Weiss G, Kruger E, Danielson U, Elman M
Can Med Assoc J. 1975 Jan 25;112(2):159-65.
Three groups of hyperactive children were compared by various measures of outcome 5 years after initial evaluation: 24 who were treated with methylphenidate for 3 to 5 years during the follow-up period, 22 treated with chlorpromazine for 18 months to 5 years, and 20 who had received no medication during the follow-up period. The three groups were matched with respect to age, IQ, socioeconomic class and sex. No statistically significant differences were found between the three groups on the following measures of outcome: emotional adjustment, delinquency, Wechsler Intelligence Scale for Children, Bender Gestalt visual-motor test and academic performance (as measured by number of grades failed). Initially there was a significant difference between the three groups on ratings of hyperactivity and family diagnosis. Hyperactivity scores decreased significantly over the 5 years; family diagnosis ratings changed little. Analysis of covariance for these two measures showed no difference in degree of improvement between the three groups. Our impression was that methylphenidate was helpful in making hyperactive children more manageable at home and at school, but did not significantly affect their outcome after 5 years of treatment.
对三组多动症儿童在初次评估5年后的各项结果指标进行了比较:24名儿童在随访期间接受了3至5年的哌甲酯治疗,22名儿童接受了18个月至5年的氯丙嗪治疗,20名儿童在随访期间未接受任何药物治疗。三组在年龄、智商、社会经济阶层和性别方面进行了匹配。在以下结果指标上,三组之间未发现统计学上的显著差异:情绪调节、犯罪行为、韦氏儿童智力量表、本德尔格式塔视觉运动测试和学业成绩(以不及格成绩数量衡量)。最初,三组在多动症评分和家庭诊断方面存在显著差异。5年期间,多动症评分显著下降;家庭诊断评分变化不大。对这两项指标进行协方差分析表明,三组之间的改善程度没有差异。我们的印象是,哌甲酯有助于使多动症儿童在家庭和学校中更易于管理,但在治疗5年后对他们的结果没有显著影响。